Skip to main content
. Author manuscript; available in PMC: 2014 Jan 6.
Published in final edited form as: J Am Coll Cardiol. 2012 Mar 27;59(13):10.1016/j.jacc.2011.10.900. doi: 10.1016/j.jacc.2011.10.900

Table 1.

Summary of SCD Right Heart Catheterization Studies

Hemodynamic values from right heart catheterization studies in SCD.

First Author (Ref.#) Number of Subjects Screened Exclusions Criteria for RHC Number of RHCs Number of Subjects with PH* % of RHC with PH % of Screened Subjects with PH Mean Age of PH Subjects mPAP (mmHg) PVR (dyne* sec/cm5) CO (Liters/min) 6MWD (m) Duration of Follow-up (yrs) Mortality in PH group
Mehari et al.(100) 533 none TRV ≥2.8m/s 6MWD < 500m unexplained dyspnea or desaturation 86 56 65 11 41 36 ± 9 229 ± 149 8 ± 3 358 ± 113 4.4 36%
Parent et al. (85) 445 renal insufficiency restrictive lung disease liver disease TRV ≥ 2.5m/s 96 24 25 5 45 30 ± 6 138 ± 58 9 ± 2 404 ± 94 2.2 13%
Fonseca et al (84) 80 none TRV ≥ 2.5m/s 26 8 31 10 46 33 ± 9 179 ± 120§ 5 ± 2£ 460 ± 152 2.8¤ 38%
*

Pulmonary hypertension defined as mean PAP≥25mmHg

#

Median (interquartile range)

§

converted mean value: PVR measured in Woods units as 2.24 ±1.5

£

Cardiac index (L/min/m2)

¤

Estimated from figure in epub